IRIS
COSTANZO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.479
AS - Asia 3.162
EU - Europa 3.044
SA - Sud America 392
AF - Africa 59
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
Totale 26.159
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.376
SG - Singapore 1.408
CN - Cina 793
DE - Germania 456
UA - Ucraina 429
RU - Federazione Russa 425
BR - Brasile 335
HK - Hong Kong 304
IT - Italia 301
SE - Svezia 276
VN - Vietnam 267
IE - Irlanda 261
FR - Francia 223
GB - Regno Unito 220
PL - Polonia 194
FI - Finlandia 125
JP - Giappone 92
KR - Corea 83
CA - Canada 61
IN - India 42
NL - Olanda 27
BE - Belgio 26
AR - Argentina 23
BD - Bangladesh 21
MX - Messico 20
TR - Turchia 20
ZA - Sudafrica 19
ES - Italia 18
IQ - Iraq 14
AT - Austria 12
IL - Israele 12
KG - Kirghizistan 12
PK - Pakistan 12
AU - Australia 11
UZ - Uzbekistan 11
CL - Cile 10
EG - Egitto 9
ID - Indonesia 9
TN - Tunisia 9
EC - Ecuador 8
EU - Europa 8
MY - Malesia 8
RO - Romania 8
TH - Thailandia 8
CH - Svizzera 7
PH - Filippine 7
CO - Colombia 6
KZ - Kazakistan 6
PY - Paraguay 6
SA - Arabia Saudita 6
DK - Danimarca 5
DO - Repubblica Dominicana 5
MA - Marocco 5
DZ - Algeria 4
HN - Honduras 4
LT - Lituania 4
OM - Oman 4
AL - Albania 3
CY - Cipro 3
ET - Etiopia 3
GR - Grecia 3
IR - Iran 3
JM - Giamaica 3
KE - Kenya 3
NP - Nepal 3
PT - Portogallo 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
CZ - Repubblica Ceca 2
GA - Gabon 2
GH - Ghana 2
HR - Croazia 2
JO - Giordania 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
VC - Saint Vincent e Grenadine 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CU - Cuba 1
EE - Estonia 1
FJ - Figi 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MM - Myanmar 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
Totale 26.153
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.820
Wilmington 3.885
Houston 3.424
Ann Arbor 895
Singapore 826
Fairfield 801
Chandler 635
Ashburn 582
Seattle 395
Jacksonville 394
San Jose 339
Beijing 315
Hong Kong 297
Cambridge 290
Dublin 259
Medford 220
Dearborn 178
Kraków 170
New York 160
The Dalles 137
Santa Clara 118
Lawrence 102
Dallas 99
Los Angeles 94
Zhengzhou 84
Tokyo 74
Ho Chi Minh City 68
Hanoi 67
Mülheim 67
Moscow 62
Council Bluffs 57
Boardman 54
Munich 54
Buffalo 53
Milan 51
San Diego 49
São Paulo 47
Menlo Park 43
Rome 43
Helsinki 35
Lauterbourg 34
San Mateo 34
Chicago 31
Falls Church 31
Shanghai 30
Brussels 24
London 24
Nuremberg 21
Redwood City 21
Montreal 19
Brooklyn 18
Hefei 18
Orem 18
Saint Petersburg 17
Atlanta 16
Columbus 16
Mountain View 16
Nanjing 16
Toronto 16
University Park 15
Warsaw 15
Frankfurt am Main 14
Turin 14
Manchester 13
Stockholm 13
Ankara 12
Chongqing 12
Da Nang 12
Amsterdam 11
Guangzhou 11
Kunming 11
Norwalk 11
Auburn Hills 10
Chennai 10
Hangzhou 10
Jinan 10
Johannesburg 10
Phoenix 10
Pune 10
Redondo Beach 10
San Francisco 10
Belo Horizonte 9
Perugia 9
Poplar 9
Suzhou 9
Boston 8
Nürnberg 8
Verona 8
Wuhan 8
Alexandria 7
Changsha 7
City of London 7
Denver 7
Detroit 7
Haiphong 7
Rio de Janeiro 7
Saint Louis 7
Campinas 6
Elk Grove Village 6
Paris 6
Totale 21.159
Salva come PNG Salva come JPEG
Nome #
The p53/p63/p73 family of transcription factors: overlapping and distinct functions 538
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis 535
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis 523
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 495
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage 494
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 489
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 480
Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage 472
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 466
Ascorbate up-regulates MLH1 (Mut L homologue-1) and p73: Implications for the cellular response to DNA damage 466
Actinic keratosis treated with an immune response modifier: a case report of six patients 457
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 453
MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide-induced apoptosis 451
IL-21 in the pathogenesis and treatment of skin diseases 442
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 438
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 437
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population 429
Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain 427
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 426
Structure, function and regulation of p63 and p73 425
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage 422
PSORS2 markers are not associated with psoriatic arthritis in the Italian population 414
Herpes simplex virus disrupts NF-kappa B regulation by blocking its recruitment on the I kappa B alpha promoter and directing the factor on viral genes. 413
Induction of neuronal differentiation by p73 in a neuroblastoma cell line 407
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 407
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 406
Pathogenic role of interleukin-21 in psoriasis 400
Elementi di dermatologia 400
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice 397
Zosteriform metastasis of occult bronchogenic carcinoma 381
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene 375
Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants  and  373
Two new p73 splice variants, gamma and delta, with different transcriptional activity 364
Efficacy and safety of long-term infliximab therapy in moderate to severe psoriasis and psoriatic arthritis 362
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 358
IL-21, a new player in pathogenesis of psoriasis 354
Zosteriform metastasis of occult bronchogenic carcinoma 353
Psoriasis: from pathogenesis to novel therapeutic approaches 352
Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model 343
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 340
High-dose Intravenous Immunoglobulin for Severe Drug Reactions: Efficacy in Toxic Epidermal Necrolysis 335
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate to severe plaque-type psoriasis: Results from extension phase of the SUPREME study 252
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 214
Treatment of vitiligo with the 308 nm excimer laser 208
Claudin-1 is a p63 target gene with a crucial role in epithelial development 208
308 nm monochromatic excimer light in the treatment of psoriasis 201
A feedback regulatory loop between p63 and Dlx3: implications for epidermal differentiation 194
Safety and efficacy study on etanercept in patients with plaque psoriasis 190
Different applications of monochromatic excimer light in skin diseases 187
Cross-talks in the p53 family - Delta Np63 is an anti-apoptotci target for Delta Np73 alpha and p53 gain-of-function mutants 185
Efalizumab 185
The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab 177
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 176
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers 175
p63 and p73 transactivate differentiation gene promoters in human keratinocytes 174
Treasure or artifact: a decade of p63 research speaks for itself 173
Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides 173
A role of p73 in mitotic exit 172
p63 induces key target genes required for epidermal morphogenesis 172
Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways 166
Moderate and severe plaque psoriasis: Cost-of-illness study in Italy 165
Consecutive use of different biological therapies in the treatment of psoriasis [4] 164
Long-term treatment of plaque psoriasis with efalizumab: an Italian experience 158
Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects 157
The p73 gene is an anti-tumoral target of the RAR beta/gamma-selective retinoid tazarotene 157
RelA/NF-kappa B recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells 152
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappa B subunits on IL-8 and Bcl-xL gene promotors 152
Homeobox gene Dlx3 is regulated by p63 during ectoderm development: relevance in the pathogenesis of ectodermal dysplasias 152
DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes 150
Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells 149
Safety and efficacy study on etanercept in patients with plaque psoriasis 149
p73 is regulated by phosphorylation at the G2/M transition 147
NF-κB, IκB Kinase and Interacting Signal Networks in Squamous Cell Carcinomas 147
Pharmacological treatment of androgenetic alopecia.Result of an observational study 145
Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells 144
deltaEF1 repressor controls selectively p53 family members during differentiation 143
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters 143
A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes 142
Differential regulation of E2F1 apoptotic target genes in response to DNA damage 140
The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting 139
Emerging treatments in the management of psoriasis: biological targeting with ustekinumab 134
Efficacy and safety of etanercept in psoriasis after switching from other treatments: An observational study 132
Etanercept for the treatment of severe childhood psoriasis [3] 128
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis 128
Delta Np63 Knockdown Mice: A Mouse Model for AEC Syndrome 124
Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis 123
Assessment of HLA Cw6 genotype and correlation to ustekinumab response in a large cohort of patients with moderate-to-severe psoriasis 121
HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis 118
Pharmacogenomics: getting closer to a tailored therapy? 114
Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: A report of two cases 110
DNp73 alpha protects myogenic cells from apoptosis 107
Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris 106
Label-free and non-invasive discrimination of HaCaT and melanoma cells in a co-culture model by hyperspectral confocal reflectance microscopy 93
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis 90
HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-up 87
Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis 84
Keratosis punctata palmoplantaris and malignancies: case report 83
Human leucocyte antigen Cw6 predisposes to clinical response to the inlterleukin-12/23 blocker ustekinumab: results of long-term treatment 83
Ustekinumab for treatment of plaque psoriasis in a patient with down syndrome 80
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis) 77
Totale 25.998
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.114
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.114
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021297 0 0 0 0 0 0 0 0 0 0 222 75
2021/20221.136 34 90 111 62 29 116 43 59 83 121 59 329
2022/20231.513 166 132 83 245 134 312 83 74 149 6 94 35
2023/2024519 73 18 29 19 42 140 21 68 3 5 6 95
2024/20252.028 114 420 214 156 38 151 161 98 171 148 194 163
2025/20263.605 353 229 516 311 283 129 460 387 461 446 30 0
Totale 26.394